Heart Institute News

Physicians can use late gadolinium enhancement technique to identify high-risk hypertrophic cardiomyopathy patients.

An investigational clinical trial at Children’s Hospital Los Angeles is testing the Autus pulmonary valve, which can be size-adjusted as a child grows.

Jondavid Menteer, MD, was recognized for two decades of dedication and leadership in pediatric heart transplant.

The novel vascular stent creates a new and minimally invasive treatment option for babies and young children with congenital heart defects.

As a pioneer in the Pediatric RN Residency concept, CHLA continues its legacy of training new nurses to deliver next-level care.

Two cardiologists from Children’s Hospital Los Angeles share key learnings from CHLA’s Pediatric Acute Heart Failure Symposium.

Jacqueline Szmuszkovicz, MD, described the overlapping clinical features of post-COVID syndrome MIS-C, and another rare illness, Kawasaki disease

CHLA’s Cardiogenomics team cares for three siblings after it was found they inherited a dangerous heart condition called hypertrophic cardiomyopathy.

A CHLA study shows that increased risks for the Ross in neonates and infants are due to more complex heart disease, not a child’s age.

The specialized Fetal Cardiology Program in the Heart Institute at CHLA helps kids like E.J. who are born with heart defects grow up stronger and healthier.